NABPTX化疗方案是以纳米化紫杉醇(Nab-paclitaxel)为主要药物的化疗方案。该方案通常用于乳腺癌、非小细胞肺癌和胰腺癌等多种恶性肿瘤的治疗。纳米化紫杉醇是一种通过把传统的紫杉醇纳米化而得到的新型抗癌药物。 二、NABPTX化疗方案的作用机制 NABPTX化疗方案的作用机制主要包括两个方面。首先,纳米化紫杉醇能够通过改变...
Nab-PTX(白蛋白结合型紫杉醇)+ATZ能够将功能性CD8 T细胞从耗竭状态转变为干细胞样效应记忆表型,将功能性CD4 T细胞转变为具有干细胞样特征的Tfh状态,减少Treg和抑制性巨噬细胞,阻止cDC1和cDC2转变为免疫调节状态,从而促进强大而持续的T细胞反应; PTX+ATZ的应答者表现出CD8 Tex和CD4 Tfh增加,Treg和抑制性巨噬细胞升...
Cy5-Nab-PTX 荧光标记白蛋白结合型紫杉醇 是由西安齐岳生物科技有限公司提供科研类试剂 货号规格数量价格 Q-0097320100mg 1 询价 Q-0097320250mg 1 询价 Q-0097320500mg 1 询价 Q-00973201g 1 询价 Q-00973205g 1 询价 快速订购/大包装咨询 张惠宁销售经理 ...
The aim of this study is to evaluate efficacy and safety of nab-PTX and nab-PTX combined with ICIs for relapsed SCLC.Methods:We retrospectively reviewed relapsed SCLC patients who were given nab-PTX (130mg/m2, day1,8 /Q3 weeks) or nab-PTX combined with ICIs (PD-1 or PD-L1), from ...
摘要: Nanoparticle albumin-bound paclitaxel (nab-PTX) is 关键词:Peripheral neuropathy nab-paclitaxel compression therapy goshajinkigan.被引量: 5 年份: 2014 收藏 引用 批量引用 报错 分享 全部来源 免费下载 求助全文 Semantic Scholar (全网免费下载) 相似文献 参考文献 引证文献Final results of a phase ...
Methods Two hundred patients with pancreatic cancer who received GEM + nab-PTX were retrospectively investigated. Frequency and risk factor(s) of suspension of the treatment and grade 3/4 neutropenia in the first course were evaluated. Results The frequency of treatment suspension in the first ...
A phase Ib extension study of cancer stemness inhibitor BB608 (napabu- casin) in combination with gemcitabine and nab-paclitaxel (nab-PTX) in patients (pts) with metastatic pancreatic cancer. Poster presented at: ASCO 2016 Annual Meeting [abstract 4128]. 71. Bahary N, Garrido-Laguna I, ...
+ PTX in terms of response rate (RR) and non-inferiority in terms of progression free survival (PFS) and overall survival (OS) in untreated patients with stage IIIB/IV non-small cell lung cancer; no clinical findings have so far been reported on maintenance therapies with nab-PTX. The...
Ramcirumab (RAM) plus paclitaxel (PTX) is the standard second-line chemotherapy for metastatic gastric cancer. The ABSOLUTE trial showed that weekly nanoparticle albumin-bound (nab)-PTX was non-inferior to weekly PTX in terms of overall survival (OS). [Objective] This study aimed to evaluate...
+ PTX in terms of response rate (RR) and non-inferiority in terms of progression free survival (PFS) and overall survival (OS) in untreated patients with stage IIIB/IV non-small cell lung cancer; no clinical findings have so far been reported on maintenance therapies with nab-PTX. The...